Global Micro-RNA Sequencing and Assay Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Micro-RNA Sequencing and Assay Market Research Report 2024
MicroRNA sequencing (miRNA-seq), a type of RNA-Seq, is the use of next-generation sequencing or massively parallel high-throughput DNA sequencing to sequence microRNAs, also called miRNAs. miRNA-seq differs from other forms of RNA-seq in that input material is often enriched for small RNAs. miRNA-seq allows researchers to examine tissue-specific expression patterns, disease associations, and isoforms of miRNAs, and to discover previously uncharacterized miRNAs. Evidence that dysregulated miRNAs play a role in diseases such as cancer has positioned miRNA-seq to potentially become an important tool in the future for diagnostics and prognostics as costs continue to decrease.Like other miRNA profiling technologies, miRNA-Seq has both advantages (sequence-independence, coverage) and disadvantages (high cost, infrastructure requirements, run length, and potential artifacts).
According to MRAResearch’s new survey, global Micro-RNA Sequencing and Assay market is projected to reach US$ 429.3 million in 2033, increasing from US$ 231 million in 2022, with the CAGR of 9.8% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Micro-RNA Sequencing and Assay market research.
Key companies engaged in the Micro-RNA Sequencing and Assay industry include Illumina, Thermo Fisher Scientific, QIAGEN, Takara Bio and NEB, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Micro-RNA Sequencing and Assay were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Micro-RNA Sequencing and Assay market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Micro-RNA Sequencing and Assay market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Illumina
Thermo Fisher Scientific
QIAGEN
Takara Bio
NEB
Segment by Type
Sequencing by Synthesis
Sequencing by Nanopore
Ion Semiconductor Sequencing
Research Institute
Academia
CRO
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Micro-RNA Sequencing and Assay report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
According to MRAResearch’s new survey, global Micro-RNA Sequencing and Assay market is projected to reach US$ 429.3 million in 2033, increasing from US$ 231 million in 2022, with the CAGR of 9.8% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Micro-RNA Sequencing and Assay market research.
Key companies engaged in the Micro-RNA Sequencing and Assay industry include Illumina, Thermo Fisher Scientific, QIAGEN, Takara Bio and NEB, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Micro-RNA Sequencing and Assay were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Micro-RNA Sequencing and Assay market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Micro-RNA Sequencing and Assay market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Illumina
Thermo Fisher Scientific
QIAGEN
Takara Bio
NEB
Segment by Type
Sequencing by Synthesis
Sequencing by Nanopore
Ion Semiconductor Sequencing
Segment by Application
Research Institute
Academia
CRO
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Micro-RNA Sequencing and Assay report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source